News Conference News ACC 2012 Three Months of Antiplatelet Therapy with Endeavor Equal to 1 Year with Other DES Jason Kahn March 24, 2012
News Daily News Experts Give Their Picks for Most Important Developments of 2011 Jason Kahn March 08, 2012
News Daily News Angiotensin Blocker Preserves Endothelial Function Better Than Calcium Antagonist Jason Kahn March 05, 2012
News Daily News Resolute Integrity: New Zotarolimus-Eluting Stent Gains FDA Approval L.A. McKeown February 20, 2012
News Daily News Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES Jason Kahn January 08, 2012
News Daily News Clopidogrel Prescriptions Not Being Filled Fast Enough, If at All Yael L. Maxwell December 14, 2011
News Daily News Stenting, Surgery Achieve Good Hemodynamic Outcomes in Native Aortic Coarctation Jason Kahn December 04, 2011
News Conference News Paclitaxel-Eluting Bioabsorbable Stent Shows Advantage over Bare-Metal Version November 20, 2011
News Conference News ‘Judicious Use’ of DES in Low-Risk Patients Could Save Over $200 Million per Year November 16, 2011
News Industry News REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES November 13, 2011
News Daily News DES Associated with Less Downstream Lesion Development than BMS L.A. McKeown November 04, 2011
News Industry News Elixir Medical Corporation Announces Successful Completion of First-In-Man Study Enrollment for Fully Bioresorbable Drug Eluting Coronary Scaffold System November 02, 2011
News Daily News Early Study Shows Pelvic Stenting for Erectile Dysfunction Safe, Feasible October 21, 2011
News Daily News DES Shows Slight Edge Over BMS in Patients with Kidney Disease L.A. McKeown October 21, 2011
News Industry News Boston Scientific Begins Clinical Trial Enrollment for OMEGA™ Platinum Chromium Stent System October 05, 2011
News Daily News Long-term Outcomes Similar for Biodegradable-Polymer, Permanent-Polymer DES September 12, 2011